NDMA consumer survey reports high marks for OTC safety, convenience, value.
This article was originally published in The Rose Sheet
OTC SAFETY, CONVENIENCE RECEIVE HIGH MARKS BY CONSUMERS in the first mailing of a consumer confidence tracking study conducted on behalf of the Nonprescription Drug Manufacturers Association. Speaking at NDMA's annual meeting in Colorado Springs on May 19, Sandoz Pharmaceuticals Director-Marketing, Research and Planning Mark Sanderson reported that 91% of 250 participating consumers agreed that "OTCs are safe" and 94% agreed that OTC drugs are "convenient to buy."
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review